A generally planar micro injector with a securing lanyard is disclosed. The micro injector is constructed of an elastic ampoule with a flexible actuation area affixed to a thin base unit through which an injector needle is plumbed. The micro injector is secured to the hand with an adhesive layer and an affixed securing lanyard and has a flexible, collapsible ring constructed of thin film circumferentially attached around its base. The flexible, collapsible ring is filled with anesthetic gel and extends beyond the tip of the needle.

The present invention provides novel medical devices for use in surgical procedures and methods for manufacturing novel medical devices. In some embodiments, the novel medical devices can include surgical needles that are capable of being repeatedly passed through tissue using minimal force. More particularly, the surgical needles can be manufactured with one or more coatings that provide the surgical needles with both durability and lubricity for ease of repeated and successive passes through tissue. Novel methods for manufacturing the surgical needles and for providing and applying coatings to the surgical needles are also provided.

A method of treating a spinal disk according to the present invention can include inserting an alloplastic bulking agent into the spinal disk to treat the defect. The alloplastic bulking agent has a plurality of microparticles and a suspending agent comprising hyaluronic acid. The bulking agent results in at least one of sealing the defect, increasing a pressure of the disk, increasing a height of the disk, improving stability of the disk and improving structural integrity of the disk.

A facemask includes integrated actuating modules having sensors and other mechanisms. The facemask has one or more sockets into which various modules may be inserted. The facemask itself or the modules may include air filters and check valves to regulate airflow along or through the various modules. The modules may detect various substances either in the ambient air or the air exhaled by the wearer. The facemask also includes modules for measuring pulmonary and/or cardiovascular exertion, lung capacity and other physiological metrics. Other modules may provide supplements, vitamins or other substances such as tobacco smoke or vapor from vaporizers to the wearer. The modules may include microcontrollers in wireless communication with software applications on electronic devices so that the facemask may also serve as a cellular phone.

One embodiment is directed to a system for injecting, comprising a syringe body defining an interior medicine chamber; a stopper member configured to be inserted into the interior medicine chamber to contain medicine within the medicine chamber; a plunger member configured to be manually manipulated to insert the stopper member relative to the syringe body; and a needle having proximal and distal ends, the proximal end comprising an anchoring geometry configured to be at least partially inserted into the stopper member such that upon retraction of the stopper member, the needle is pulled proximally along with the stopper to be at least partially contained within the interior medicine chamber.

A syringe protecting device equipped with an outer cylinder, an inner cylinder and a spring, wherein, when the spring is released from its compressed state, the inner cylinder is moved rearward with respect to the outer cylinder so that a syringe needle is stored inside the outer cylinder, and the syringe protecting device further equipped with a releasable pre-locking mechanism for fixing the inner cylinder to the outer cylinder while maintaining the spring in the compressed state in the front-rear direction, wherein, the pre-locking mechanism fixes the inner cylinder before movement to the outer cylinder by engaging the protruding sections of the ring with the engaging sections of the through groove sections.

A port-a-cath needle adapted for determining the position of the needle prior to dispensing medical treatments is disclosed. Disclosed embodiments of the port-a-cath needle comprises a cannula, a hollow needle, and an inflatable balloon. The balloon is disposed at the distal end of the port-a-cath needle such that when the needle is inserted into a patient, the balloon may be inflated and the resistance pressure used to determine if the needle is inserted into the port chamber or a port-a-cath device or is surrounded by soft tissue. In certain embodiments, the balloon may be maintained in the inflated configuration in order to help retain the port-a-cath needle within the port chamber while treatment is delivered to the patient.

A flexible medical needle for extended indwelling periods is provided. The medical needle apparatus includes a spine body and a flexible shaft portion. The spine body has a length between a first end, comprising a piercing tip, and a second end. The flexible shaft portion may be disposed on at least a portion of the spine body, forming a needle shaft having a passage along a portion of the length of the spine body. The spine body may also be coiled forming an axial passage within the spine body. In this latter embodiment, the flexible shaft portion surrounds the spine body. In each embodiment, the spine body is configured to facilitate bending, allowing for the medical needle to remain indwelling with reduced discomfort.

A method of treating plantar fasciitis or chronic heel spur syndrome includes inserting a first needle having a distal tip into a plantar aspect of a foot and advancing the distal tip to a location where a plantar fascia originates, and inserting a second needle having a distal tip into a medial aspect of the foot and advancing the distal tip of the second needle to the location where the plantar fascia originates. Medical imaging confirms that the distal tips of the first and second needles are located where the plantar fascia originates. After medical imaging, the second needle is removed from the foot, and a third needle having a sharpened distal tip is inserted into a medial opening formed by the second needle. The sharpened distal tip of the third needle is advanced through the medial opening to the location where the plantar fascia originates. Medical imaging confirms the location of the sharpened distal tip of the third needle. The sharpened distal tip of the third needle is used to cut the plantar fascia. After cutting the plantar fascia, the third needle is removed from the foot. A fourth needle coupled with a syringe containing a growth factor is inserted into the medial opening in the foot, and a distal tip of the fourth needle is advanced to the location where the plantar fascia originates. Medical imaging confirms the location of the distal tip of the fourth needle. The syringe coupled with the fourth needle is engaged for injecting the growth factor into the plantar fascia.

A mini syringe includes a tubular base member, a microneedle unit including a microneedle device and a compressible pharmacy housing device and mounted in the bottom side of the base member, a plunger mounted in the base member and pressable to compress the pharmacy housing device, and an adjustment cover threaded onto the base member for controlling the moving distance of the plunger in a micro-adjustable manner.